NCT02384473View on ClinicalTrials.gov

Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 24, 2014

Primary Completion Date

January 19, 2024

Study Completion Date

January 19, 2024

Conditions
Adult Soft Tissue SarcomaBone SarcomaRetroperitoneal Sarcoma
Interventions
PROCEDURE

Real-Time CEUS

Undergo real-time CEUS

PROCEDURE

SWE

Undergo SWE

DRUG

Definity Suspension for Injection

Participant will receive contrast agent by intravenous administration

DEVICE

Philips Shear Wave Elastography

Type of equipment used for SWE

Trial Locations (1)

90033

USC Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT02384473 - Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter